Pharmathen
Pharmaceutical ManufacturingAttica, Greece1001-5000 Employees
Pharmathen, founded in 1969 and based in Marousi, Attica, Greece, is a pharmaceutical manufacturing company focused on complex drug delivery technologies. Its core areas include long-acting injectables, sustained-release formulations, and ophthalmic products, produced in Greece at US FDA- and EU-approved facilities and distributed to patients in more than 90 countries through about 250 customers. The company emphasizes collaboration with partners to advance innovative therapies and lifecycle-management opportunities, leveraging its three certified technological platforms and broad global reach. In December 2024, Pharmathen and Neuraxpharm announced a co-development agreement to advance long-acting injectable therapies for psychiatry.